← Non-small cell lung cancer investigators

Jin Hyoung Kang

Seoul St. Mary's Hospital, The Catholic University of Korea · The Catholic University of Korea · Seoul St'. Mary's Hospital

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

9 more share only the name and are not shown

Trial papers in non-small cell lung cancer

PubMed author-name match

Trials

Studies that name Jin Hyoung Kang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:15 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT05477615 · Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases
Jin Hyoung Kang · terminated · Non-small Cell Lung Cancer · study chair
Ph2
NCT05326425 · Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.
Jin Hyoung Kang · unknown · Lung Neoplasms · study chair
N/A
NCT04930133 · Retrospective Multi-cohort Study of Frontline Afatinib Followed by 2nd Line Therapy Including Osimertinib, Chemotherapy or Other Therapy
Seoul St. Mary's Hospital · unknown · NSCLC · study chair
Ph4
NCT02532634 · Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone
Kangdong Sacred Heart Hospital · completed · Cancer, Tumors · principal investigator
Ph4
NCT01659775 · Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
LG Life Sciences · completed · Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) · principal investigator
N/A
NCT01619241 · Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer
The Catholic University of Korea · unknown · Non-small Cell Lung Cancer · principal investigator
Ph2
NCT01497873 · A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
Chong Kun Dang Pharmaceutical · completed · Small Cell Lung Cancer · principal investigator
Ph2
NCT00535015 · Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
Anaborex · terminated · Anorexia, Cachexia, Weight Loss · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name in non-small cell lung cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:15 UTC. The ranking covers the 200 most relevant of 44 PubMed records, and a shared surname and initials can bring in a namesake. All 44 on PubMed